1. Home
  2. URGN vs NBHC Comparison

URGN vs NBHC Comparison

Compare URGN & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$47.11

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo National Bank Holdings Corporation

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$43.19

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
URGN
NBHC
Founded
2004
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
URGN
NBHC
Price
$47.11
$43.19
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$29.29
$47.67
AVG Volume (30 Days)
795.1K
428.9K
Earning Date
05-06-2026
04-21-2026
Dividend Yield
N/A
3.03%
EPS Growth
N/A
N/A
EPS
N/A
1.04
Revenue
$1,128,000.00
$47,100,000.00
Revenue This Year
$129.09
$39.96
Revenue Next Year
$70.96
$7.14
P/E Ratio
N/A
$41.19
Revenue Growth
N/A
2.86
52 Week Low
$15.86
$35.06
52 Week High
$48.19
$47.28

Technical Indicators

Market Signals
Indicator
URGN
NBHC
Relative Strength Index (RSI) 67.57 47.20
Support Level $18.23 $42.95
Resistance Level N/A $43.98
Average True Range (ATR) 2.39 0.85
MACD 0.35 -0.08
Stochastic Oscillator 86.58 57.07

Price Performance

Historical Comparison
URGN
NBHC

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.

Share on Social Networks: